-+ 0.00%
-+ 0.00%
-+ 0.00%
RaySearch software enables first patient treatment in conformal FLASH proton therapy trial
Share
Listen to the news
RaySearch software enables first patient treatment in conformal FLASH proton therapy trial
  • RaySearch Laboratories' investigational RayStation software supported the first patient treatment in the C-FLASH-01 conformal FLASH proton therapy trial at Penn Medicine.
  • The IBA-sponsored study will enroll 10 patients requiring repeat radiation treatment for head and neck cancer.
  • Treatments use IBA's ConformalFLASH technology on the ProteusPLUS proton therapy system under an FDA-authorized investigational device exemption.
  • The trial will primarily assess treatment feasibility and acute toxicity, with secondary measures covering delivery accuracy, longer-term safety and patient outcomes.
  • FLASH delivers radiation in a fraction of a second, potentially sparing healthy tissue; clinical benefits have yet to be established.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. RaySearch Laboratories AB published the original content used to generate this news brief on November 17, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending